Steroid-responsive meningitis-arteritis (SRMA) is an immune-mediated condition in dogs where the body’s own immune system attacks the protective membranes surrounding the brain and spinal cord, along with nearby blood vessels. It primarily strikes young adult dogs and causes intense neck pain, fever, and a stiff gait. The good news: with proper treatment, all cases typically respond to medication, and the long-term prognosis is generally good.
What Happens Inside the Body
SRMA is not caused by an infection. Instead, the dog’s immune system misfires, triggering inflammation in two key areas: the leptomeninges (the delicate inner layers wrapping the brain and spinal cord) and the walls of nearby arteries. This inflammation is driven primarily by a flood of neutrophils, a type of white blood cell that normally fights bacteria but in this case causes damage to healthy tissue.
The inflammation tends to concentrate around the cervical spinal cord, which is the section running through the neck. In the acute form, the arterial walls develop a specific pattern of damage called fibrinoid necrosis, where the vessel lining breaks down. Blood clots can form inside these damaged vessels, and small hemorrhages may occur in the surrounding meningeal tissue. Macrophages and lymphocytes also pile into the affected areas, compounding the inflammatory damage.
Which Dogs Are Most Affected
SRMA most commonly appears in young adult dogs, typically between 6 months and 2 years of age. Certain breeds are overrepresented, including Beagles, Bernese Mountain Dogs, Boxers, and Nova Scotia Duck Tolling Retrievers, though any breed can develop the condition. The exact trigger remains unknown, but the breed predisposition suggests a genetic component to the immune system dysfunction.
Recognizing the Symptoms
The hallmark of acute SRMA is severe neck pain. Dogs hold their heads low and resist looking up, turning, or being touched around the neck and upper spine. Their gait becomes stiff and guarded, as if every step hurts. Fever is a consistent feature. Many dogs become reluctant to move, eat, or engage with their owners, and some cry out when their neck or back is touched. The pain sensitivity can extend along the entire spinal cord, not just the neck.
A chronic form also exists, though it’s less common. Dogs with chronic SRMA may develop neurological deficits like wobbliness or weakness in the limbs, because prolonged inflammation can damage the spinal cord or its blood supply over time. This form sometimes develops when the acute phase goes untreated or is treated too briefly.
How SRMA Is Diagnosed
Your vet will suspect SRMA based on the combination of neck pain, fever, and the dog’s age and breed. But confirming it requires a spinal tap, where a small sample of cerebrospinal fluid (CSF) is collected under anesthesia. In dogs with SRMA, this fluid shows a dramatic increase in neutrophils, the same immune cells driving the inflammation.
Blood tests also play a role. C-reactive protein (CRP), a general marker of inflammation, is typically elevated and serves as a useful, cost-efficient way to both support the diagnosis and track treatment response over time. Elevated levels of an antibody called IgA in both the blood and CSF further support an SRMA diagnosis. However, no single biomarker is specific to SRMA alone, so your vet will also need to rule out infections, cancer, and other inflammatory brain diseases through imaging and additional testing.
Treatment: A Long Course of Steroids
The cornerstone of SRMA treatment is corticosteroids, specifically prednisolone or prednisone. Treatment starts at a high dose to rapidly suppress the overactive immune response, then follows a carefully structured tapering schedule over approximately six months. A widely used protocol begins with higher twice-daily dosing for the first two weeks, then steps down through several six-week phases of progressively lower doses before finally stopping.
This slow taper is critical. A large study comparing a six-week course to a six-month course found that dogs on the shorter protocol relapsed at a rate of 38%, compared to 30% on the longer protocol. Cutting treatment short is one of the most common reasons for relapse, even when a dog appears to feel completely better within the first week or two. Your vet will likely recheck CRP levels and potentially repeat the spinal tap during treatment to confirm the inflammation has truly resolved before reducing the dose further.
What to Expect During Treatment
Steroids at immunosuppressive doses come with noticeable side effects that you’ll live with for months. Your dog will likely drink significantly more water, urinate far more frequently (including possible accidents in the house), and have an increased appetite. Weight gain is common. These effects are most pronounced during the early high-dose phase and gradually improve as the dose tapers down.
Urinary tract infections are the most significant medical concern during long-term steroid use, occurring in up to 30% of dogs on extended courses. What makes this tricky is that steroids suppress the inflammation and discomfort that normally signal a UTI, so your dog may show no obvious signs of infection. Your vet will likely recommend periodic urine cultures to catch infections early, even if your dog seems fine. Skin changes, panting, and a pot-bellied appearance can also develop with prolonged use but resolve after treatment ends.
When Steroids Aren’t Enough
Some dogs are severely affected from the start or don’t respond adequately to steroids alone. In these refractory cases, a second immunosuppressive medication is added alongside steroids. Options include azathioprine, cyclosporine, mycophenolate, and leflunomide. These drugs work through different pathways to further dampen the immune response. The choice depends on the individual dog’s situation, other health conditions, and how they tolerate the medication.
Relapse and Long-Term Outlook
Overall, about 34% of dogs with SRMA experience at least one relapse. Among those that do relapse, the majority (67%) relapse only once. A smaller percentage relapse two or three times. Relapses look similar to the original episode, with a return of neck pain, fever, and stiffness, and they’re treated by restarting or adjusting the steroid protocol.
The reassuring reality is that SRMA carries a good prognosis. In published studies, all dogs responded to their treatment protocol, and a six-month steroid course led to clinical remission with at least six months of disease-free time afterward. Dogs that complete treatment and avoid relapse go on to live normal lives. Even those that relapse can typically be brought back into remission with a second round of therapy. The key is committing to the full treatment duration and keeping up with monitoring appointments, even when your dog seems perfectly healthy again.